About this trial
Your research study is about evaluating the effectiveness of \*\*Mindfulness-Based Cognitive Therapy (MBCT)\*\* in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC).
The study highlights that psoriasis patients often suffer not only from physical symptoms but also from psychological problems such as stress, anxiety, depression, self-judgment, and low self-compassion. Traditional treatments mainly focus on physical symptoms and may not fully address these emotional and psychological difficulties.
To address this gap, the study proposes MBCT as a psychological intervention that combines mindfulness practices with cognitive therapy techniques. MBCT helps patients become more self-aware, reduce negative thinking, and develop self-compassion without self-judgment. The research also explores MHLC, which refers to how much control individuals believe they have over their health outcomes.
The study aims to investigate whether MBCT can:
* Reduce psychological distress, anxiety, depression, and stress levels * Improve self-compassion among psoriasis patients * Shift patients' locus of control from external to internal * Enhance emotional well-being and coping mechanisms
The research follows a quantitative experimental design conducted in phases. Initially, baseline levels of distress, MHLC, and self-compassion will be assessed. Later, MBCT interventions will be implemented and evaluated for effectiveness.
Overall, the study seeks to contribute to integrated psoriasis care by emphasizing the importance of psychological health alongside physical treatment, ultimately improving patients' quality of life and therapeutic outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed psoriasis patients
Age between 18 and 65 years
Both male and female participants
Participants willing to provide informed consent
Disqualifiers
Under the age of 18 years will be excluded.
Patients with severe psychiatric disorders
Patients currently receiving other psychological therapies
Patients with serious medical or neurological conditions
Trial design
Parallel
Treatments tested in this trial
Mindfulness-Based Cognitive Therapy (MBCT)
BehavioralMindfulness-Based Cognitive Therapy (MBCT) will be administered to psoriasis patients to reduce psychological distress and improve self-compassion and mental health locus of control. The intervention includes mindfulness practices and cognitive behavioral techniques delivered in structured sessions.
Usual Care
Other interventionParticipants in the control group will receive usual care without Mindfulness-Based Cognitive Therapy intervention.
Treatment groups
Trial outcomes
Primary outcomes
Reduction in Psychological Distress
To evaluate the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in reducing psychological distress among psoriasis patients.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.